ETB115
Showing 1 - 9 of 9
Primary Immune Thrombocytopenia Trial in Singapore (Ianalumab, Eltrombopag, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- Ianalumab
- +2 more
-
Singapore, SingaporeNovartis Investigative Site
Jan 23, 2023
Severe Aplastic Anemia (SAA) Trial in Worldwide (eltrombopag, rabbit anti-thymocyte globulin (r-ATG), cyclosporine A (CsA))
Active, not recruiting
- Severe Aplastic Anemia (SAA)
- eltrombopag
- +2 more
-
Zhengzhou, Henan, China
- +11 more
Jan 23, 2023
Aplastic Anemia Trial in China (Eltrombopag 25 mg)
Active, not recruiting
- Aplastic Anemia
- Eltrombopag 25 mg
-
Nanjing, Jiangsu, China
- +4 more
Oct 7, 2021
Immune Thrombocytopenia (ITP) Trial in Germany (Eltrombopag, Dexamethasone)
Recruiting
- Immune Thrombocytopenia (ITP)
-
Mannheim, Baden-Wuerttemberg, Germany
- +24 more
Dec 19, 2022
Purpura, Thrombocytopenic, Idiopathic and Hepatitis C Trial in China (eltrombopag, )
Completed
- Purpura, Thrombocytopenic, Idiopathic and Hepatitis C
- eltrombopag
- placebo
-
Fuzhou, Fujian, China
- +17 more
Nov 22, 2019